Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. at the 2026-05-26 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-26
Exact text from the filing
Proposal No. 2: Proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified by the Company’s shareholders. Votes For Votes Against Abstentions 234,492,897.00 1,246,939.00 343,132.00
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Election of directors. at the 2026-05-26 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-26
Exact text from the filing
Proposal No. 1: Election of directors. The Company’s shareholders elected the following nominees for director to serve for three-year terms expiring at the Company’s 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal. Nominee Votes For Votes Withheld Broker Non-Votes Bernd Brust 182,998,545.00 19,825,453.49 33,258,969.51 Gregory T. Lucier 179,514,826.00 23,309,172.49 33,258,969.51 Luke Marker 182,239,834.00 20,584,164.49 33,258,969.51
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
MARAVAI LIFESCIENCES HOLDINGS, INC. shareholders approved Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. at the 2026-05-26 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-26
Exact text from the filing
Proposal No. 3: Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. The Company’s shareholders approved, on a non-binding and advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s proxy statement for the Annual Meeting. Votes For Votes Against Abstentions Broker Non-Votes 200,054,156.49 2,457,403.00 312,439.00 33,258,969.51
View on SEC.gov